New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.

doi:10.1001/jama.286.19.2450

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.

JAMA - 21 Nov 2001

Kovacs J A, Gill V J, Meshnick S, Masur H

Abstract excerpt

Pneumocystis carinii has been recognized as a human pathogen for nearly 50 years. We present a case of P carinii infection that typifies clinical presentation in the era of the acquired immunodeficiency syndrome epidemic. The high incidence of P carinii pneumonia in persons infected with human immunodeficiency virus (HIV) has served to focus laboratory and clinical research efforts on better understanding the...

Topics

AIDS-Related Opportunistic Infections
Algorithms
Anti-Infective Agents
Atovaquone
Dihydropteroate Synthase
Drug Resistance, Fungal
Fungal Proteins
Humans
Lymphoma, AIDS-Related
Male
Membrane Glycoproteins
Middle Aged
Mutation
Naphthoquinones
Pentamidine
Pneumocystis
Pneumonia, Pneumocystis
Sulfonamides

Source

Open in PubMed

Identifiers

PMID: 11712941
DOI: 10.1001/jama.286.19.2450

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics